The study, conducted by cross-referencing data from 19 scientific studies, involving over 20,000 individuals, shows an efficacy rate of over 50% in reducing disease cases, with lasting effects and a high safety profile.
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.